| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |